Feline low-grade alimentary lymphoma: an emerging entity and a potential animal model for human disease

BMC Veterinary Research

Table 2 Description and prevalence of paraclinical data abnormalities reported in alimentary lymphoma (AL)

Data	Description	Paraclinical data	AL
Data	Description	Paraclinical data	Cases	Prevalence
Albumin	Biomarker of gastrointestinal protein loss [87]	Decreased [87]	LGAL	49% (21/43) [20]
Cobalamin (Vitamin B12)	Biomarker of absorption [8, 72, 83, 92, 170]	Decreased [87]	LGAL	50–80% [2, 8, 11, 72, 75, 83, 87, 90, 94]
Cobalamin (Vitamin B12)	Biomarker of absorption [8, 72, 83, 92, 170]	Decreased [87]	AL	35,3% (6/17) whose 12 LGAL [77]
Folate (Vitamin B9)	Biomarker of absorption and dysbiosis [8, 72, 83, 86, 92, 170]	Increased or decreased [82, 87]	LGAL	37% (10/27) > 21.6 ng/ml [72]
Folate (Vitamin B9)		Increased or decreased [82, 87]	AL	31% (4/13) < 9.7 ng/ml [83, 87]
Lactate dehydrogenase (LDH)	Biomarker of cellular necrosis [171]	Increased [172]	LGAL	47% (9/19) [172]
Fecal a1 proteinase inhibitor concentration	Biomarker of gastrointestinal protein loss [87]	Increased [87]	AL	100% (8/8) [87]
Total serum protein	Biomarker of gastrointestinal protein loss [87]	Decreased [87]	AL	100% (7/7) [87]

ISSN: 1746-6148